Pfm Health Sciences, LP Werewolf Therapeutics, Inc. Transaction History
Pfm Health Sciences, LP
- $1.53 Billion
- Q4 2024
A detailed history of Pfm Health Sciences, LP transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 2,905,465 shares of HOWL stock, worth $4.59 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
2,905,465
Previous 3,398,747
14.51%
Holding current value
$4.59 Million
Previous $7.21 Million
40.32%
% of portfolio
0.28%
Previous 0.42%
Shares
13 transactions
Others Institutions Holding HOWL
# of Institutions
75Shares Held
29.2MCall Options Held
10.7KPut Options Held
500-
Ra Capital Management, L.P. Boston, MA6.14MShares$9.71 Million0.15% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$6.77 Million5.1% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$3.77 Million0.53% of portfolio
-
Bank Of America Corp Charlotte, NC2.08MShares$3.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$2.51 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $46.7M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...